HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norah A Albekairi Selected Research

SB-332235

1/2022CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T+ Itpr3tf/J mouse model of autism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norah A Albekairi Research Topics

Disease

2Autistic Disorder (Autism)
01/2022 - 01/2020
1Non-alcoholic Fatty Liver Disease
12/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2022
1Parkinson Disease (Parkinson's Disease)
04/2022
1Fibrosis (Cirrhosis)
09/2021
1Necrosis
09/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Rheumatoid Arthritis
12/2019
1Experimental Arthritis
12/2019
1Inflammation (Inflammations)
12/2019

Drug/Important Bio-Agent (IBA)

1Streptozocin (Streptozotocin)FDA Link
12/2022
1Ellagic AcidIBA
12/2022
1tofacitinibIBA
04/2022
1Janus Kinase InhibitorsIBA
04/2022
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2022
1SB-332235IBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Superoxide DismutaseIBA
09/2021
1Glutathione (Reduced Glutathione)IBA
09/2021
1Hexosaminidases (Hexosaminidase)IBA
09/2021
1CreatinineIBA
09/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021
1Interleukin-6 (Interleukin 6)IBA
09/2021
1AlbuminsIBA
09/2021
1Paclitaxel (Taxol)FDA LinkGeneric
01/2021
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2020
1NicotineFDA Link
01/2020
1MecamylamineIBA
01/2020
1LigandsIBA
01/2020
1N- (1- (3- (4- ethoxyphenyl)- 4- oxo- 3,4- dihydropyrido(2,3- d)pyrimidin- 2- yl)ethyl)- N- pyridin- 3- ylmethyl- 2- (4- trifluoromethoxyphenyl)acetamideIBA
12/2019

Therapy/Procedure

1Therapeutics
01/2020